AMERICAN INTERNATIONAL GROUP, INC. - VANDA PHARMACEUTICALS INC ownership

VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 166 filers reported holding VANDA PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is 2.80 and the average weighting 0.1%.

Quarter-by-quarter ownership
AMERICAN INTERNATIONAL GROUP, INC. ownership history of VANDA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$121,794
-39.2%
28,193
-7.2%
0.00%0.0%
Q2 2023$200,224
-2.9%
30,383
-0.0%
0.00%0.0%
Q1 2023$206,307
-7.7%
30,384
+0.5%
0.00%
-50.0%
Q4 2022$223,518
-25.7%
30,246
-0.8%
0.00%0.0%
Q3 2022$301,000
-8.5%
30,483
+1.1%
0.00%0.0%
Q2 2022$329,000
-7.6%
30,148
-4.2%
0.00%0.0%
Q1 2022$356,000
-32.1%
31,463
-5.8%
0.00%
-33.3%
Q4 2021$524,000
-11.3%
33,390
-3.1%
0.00%0.0%
Q3 2021$591,000
-22.9%
34,458
-3.3%
0.00%0.0%
Q2 2021$767,000
-18.8%
35,651
-43.3%
0.00%0.0%
Q1 2021$944,000
+7.5%
62,875
-6.0%
0.00%0.0%
Q4 2020$878,000
+144.6%
66,855
+79.8%
0.00%
+50.0%
Q3 2020$359,000
-17.5%
37,182
-2.3%
0.00%0.0%
Q2 2020$435,000
+16.9%
38,058
+5.9%
0.00%0.0%
Q1 2020$372,000
-39.9%
35,939
-4.7%
0.00%0.0%
Q4 2019$619,000
+20.4%
37,719
-2.6%
0.00%0.0%
Q3 2019$514,000
-6.9%
38,741
-1.0%
0.00%0.0%
Q2 2019$552,000
-23.0%
39,143
+0.5%
0.00%
-33.3%
Q1 2019$717,000
-31.4%
38,949
-2.6%
0.00%
-25.0%
Q4 2018$1,045,000
+33.6%
39,981
+17.4%
0.00%
+33.3%
Q3 2018$782,000
+22.8%
34,065
+1.8%
0.00%
+50.0%
Q2 2018$637,000
+34.4%
33,452
+18.8%
0.00%0.0%
Q1 2018$474,000
+5.1%
28,152
-5.1%
0.00%
+100.0%
Q4 2017$451,000
-14.7%
29,666
+0.5%
0.00%
-50.0%
Q3 2017$529,000
+18.9%
29,526
+8.1%
0.00%0.0%
Q2 2017$445,000
+40.8%
27,318
+21.1%
0.00%
+100.0%
Q1 2017$316,000
-6.0%
22,563
+7.1%
0.00%0.0%
Q4 2016$336,000
-99.9%
21,072
-0.3%
0.00%0.0%
Q3 2016$351,553,000
+48.9%
21,127
+0.2%
0.00%0.0%
Q2 2016$236,053,000
+15.1%
21,095
-13.8%
0.00%0.0%
Q1 2016$205,000,000
-10.1%
24,4810.0%0.00%0.0%
Q4 2015$228,000,000
+82210.5%
24,481
-0.2%
0.00%0.0%
Q3 2015$277,000
-99.9%
24,524
+0.1%
0.00%0.0%
Q2 2015$310,842,000
+32.8%
24,495
-2.6%
0.00%0.0%
Q1 2015$233,997,000
-35.1%
25,1610.0%0.00%
-50.0%
Q4 2014$360,306,000
+48.5%
25,161
+7.7%
0.00%
+100.0%
Q3 2014$242,601,000
-35.9%
23,372
-0.1%
0.00%
-50.0%
Q2 2014$378,434,000
+3.3%
23,389
+3.7%
0.00%0.0%
Q1 2014$366,438,000
+34.2%
22,550
+2.5%
0.00%
+100.0%
Q4 2013$273,132,000
+31.0%
22,009
+15.8%
0.00%0.0%
Q3 2013$208,452,000
+32.7%
19,002
-2.3%
0.00%0.0%
Q2 2013$157,083,00019,4410.00%
Other shareholders
VANDA PHARMACEUTICALS INC shareholders Q3 2020
NameSharesValueWeighting ↓
Palo Alto Investors LP 2,491,200$27,154,0002.37%
Profit Investment Management, LLC 281,890$3,071,0002.26%
Sio Capital Management, LLC 488,965$5,330,0002.00%
Zebra Capital Management LLC 14,766$161,0000.47%
Prairiewood Capital, LLC 50,165$547,0000.43%
TANG CAPITAL MANAGEMENT LLC 256,696$2,798,0000.42%
HUSSMAN STRATEGIC ADVISORS, INC. 156,000$1,700,0000.29%
GLOBEFLEX CAPITAL L P 100,843$1,099,0000.27%
Epoch Investment Partners, Inc. 2,757,646$30,059,0000.18%
EMC Capital Management 16,185$176,0000.15%
View complete list of VANDA PHARMACEUTICALS INC shareholders